Abstract:
Described are compositions and methods relating to cellulase/hemicellulase enzyme blends for improving the enzymatic hydrolysis of cellulosic and hemicellulosic materials, as commonly found in biomass.

Description:
PRIORITY 
       [0001]    The present application claim priority to U.S. Provision Application Ser. No. 61/038,520, filed on Mar. 21, 2008, which is hereby incorporated by reference in its entirety. 
     
    
     TECHNICAL FIELD 
       [0002]    The present compositions and methods relate to cellulase/hemicellulase enzyme blends for improving the enzymatic hydrolysis of cellulosic materials. 
       BACKGROUND 
       [0003]    The principal components of biomass are cellulose and hemicellulose. Cellulose consists of polymers of 6-1,4-linked glucose residues that are organized into higher order fibrillar structures. Hemicelluloses are heteropolysaccharides that include monosaccharides other than glucose, such as D-xylose, L-arabinose, D-mannose, D-glucose, D-galactose, and 4-O-methyl-D-glucuronic acid linked together not only by glycosidic linkages but also by ester linkages. The composition and structure of hemicellulose are more complicated than that of cellulose and can vary quantitatively and qualitatively in various woody plant species, grasses, and cereals. 
         [0004]    Cellulose can be converted into sugars, such as glucose, and used as an energy source by numerous microorganisms including bacteria, yeast and fungi for industrial purposes. Cellulosic materials can also be converted into sugars by commercially available enzymes, and the resulting sugars can be used as a feedstock for industrial microorganisms to produce products such as plastics and ethanol. However, current cellulase products generally lack the ability to hydrolyze hemicellulosic materials, which remain unconsumed in the biomass compositions and may interfere with the handling and disposal of the biomass. 
         [0005]    Accordingly, there remains a need to develop efficient enzyme systems for hydrolyzing both cellulose and hemicellulose, including the coproduction or blending of an optimized set of enzymes for converting hemicellulosic oligomers and polymers into free pentose for fermentation. Such optimized enzyme systems are desired to improve the efficiency and economics of biomass. 
       SUMMARY 
       [0006]    The present teachings provides optimized bioconverting enzyme blends, methods for producing the same, as well as methods of using the optimized bioconverting enzyme blend for converting biomass to sugar. The bioconverting enzyme blend comprises a mixture of a whole cellulase and one or more hemicellulases, the selection of which is dictated by the intended biomass substrate and processing conditions. 
         [0007]    In one aspect, an enzyme blend composition for hydrolyzing a mixture of cellulosic and hemicellulosic materials is provided, comprising: 
         [0008]    (a) a first enzyme composition comprising a cellulase, 
         [0009]    (b) a second enzyme composition comprising at least one xylanase selected from a GH10 or GH11 xylanase, and 
         [0010]    (c) a third enzyme composition comprising at least one additional hemicellulase that is not a GH10 or GH11 xylanase or not the same GH10 or GH11 xylanase as in (b), 
         [0011]    wherein the enzyme blend composition provides at least one of (i) enhanced glucan conversion or (ii) enhanced xylan conversion compared to an equivalent enzyme blend composition lacking the at least one additional hemicellulase. 
         [0012]    In some embodiments, the first enzyme composition is a whole cellulase blend from a filamentous fungus. In some embodiments, the first enzyme composition is a whole cellulase blend from a filamentous fungus supplemented with an addition amount of β-glucosidase. 
         [0013]    In some embodiments, the second enzyme composition comprises xylanase XYN2 from  Trichoderma reesei.  In some embodiments, the second enzyme composition comprises xylanase XYN3 from  Trichoderma reesei.    
         [0014]    In some embodiments, the at least one xylanase has an amino acid sequence having at least 80% identity to an amino acid sequence selected from SEQ ID NO: 1 or SEQ ID NO: 2. In some embodiments, the at least one xylanase has an amino acid sequence having at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, or even at least 99% amino acid sequence identity to identity to an amino acid sequence selected from SEQ ID NO: 1 or SEQ ID NO: 2. In particular embodiments, the at least one xylanase has an amino acid sequence selected from SEQ ID NO: 1 or SEQ ID NO: 2. 
         [0015]    In some embodiments, the at least one additional hemicellulase is selected from the group consisting of a GH54 hemicellulase, a GH62 hemicellulase, a GH27 hemicellulase, a GH36 hemicellulase, a GH5 hemicellulase, a GH74 hemicellulase, a GH67 hemicellulase, a GH28 hemicellulase, a GH11 hemicellulase, a GH10 hemicellulase, a GH3 hemicellulase, and a CE5 hemicellulase. 
         [0016]    In some embodiments, the at least one additional hemicellulase is a β-xylosidase or an arabinofuranosidase. In particular embodiments, the β-xylosidase is BXL1 from  Trichoderma reesei  and the arabinofuranosidase is ABF1, ABF2, or ABF3 from  Trichoderma reesei.  In some embodiments, the at least one additional hemicellulase is a combination of a β-xylosidase and an arabinofuranosidase. 
         [0017]    In some embodiments, the first enzyme composition is a whole cellulase blend from a filamentous fungus supplemented with an addition amount of β-glucosidase, the second enzyme composition comprises a xylanase, and the at least one additional hemicellulase is a combination of a β-xylosidase and arabinofuranosidase. 
         [0018]    In some embodiments, the at least one additional hemicellulase is a  Trichoderma reesei  hemicellulase selected from the group consisting of α-arabinofuranosidase I (ABF1), α-arabinofuranosidase II (ABF2), α-arabinofuranosidase III (ABF3), α-galactosidase I (AGL1), α-galactosidase II (AGL2), α-galactosidase III (AGL3), acetyl xylan esterase I (AXE1), acetyl xylan esterase III (AXE3), endoglucanase VI (EG6), endoglucanase VIII (EG8), α-glucuronidase I (GLR1), β-mannanase (MAN1), polygalacturonase (PEC2), xylanase I (XYN1), xylanase II (XYN2), xylanase III (XYN3), and β-xylosidase (BXL1). 
         [0019]    In some embodiments, the at least one additional hemicellulase has an amino acid sequence having at least 80% identity to an amino acid sequence selected from the group consisting of SEQ ID NO: 3, SEQ ID NO: 4, SEQ ID NO: 5, SEQ ID NO: 6, SEQ ID NO: 7, SEQ ID NO: 8, SEQ ID NO: 9, SEQ ID NO: 10, SEQ ID NO: 11, SEQ ID NO: 12, SEQ ID NO: 13, SEQ ID NO: 14, SEQ ID NO: 15, SEQ ID NO: 16, and SEQ ID NO: 17. In some embodiments, the at least one additional hemicellulase has an amino acid sequence having at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, or even at least 99% amino acid sequence identity to one of the aforementioned amino acid sequences. In particular embodiments, the at least one additional hemicellulase has an amino acid sequence corresponding to one of aforementioned amino acid sequences. 
         [0020]    In another aspect, a method for hydrolyzing a mixture of cellulosic and hemicellulosic materials is provided, comprising contacting the mixture of cellulosic and hemicellulosic materials with: 
         [0021]    (a) a first enzyme composition comprising a cellulase, 
         [0022]    (b) a second enzyme composition comprising at least one xylanase selected from a GH10 or GH11 xylanase, and 
         [0023]    (c) a third enzyme composition comprising at least one additional hemicellulase that is not a GH10 or GH11 xylanase or not the same GH10 or GH11 xylanase as in (b), 
         [0024]    thereby hydrolyzing the mixture of cellulosic and hemicellulosic materials, 
         [0025]    wherein the contacting results in at least one of (i) enhanced glucan conversion or (ii) enhanced xylan conversion compared to equivalent contacting in the absence of the at least one additional hemicellulase. 
         [0026]    In some embodiments, the first enzyme composition is a whole cellulase blend from a filamentous fungus. In some embodiments, the first enzyme composition is a whole cellulase blend from a filamentous fungus supplemented with an addition amount of β-glucosidase. 
         [0027]    In some embodiments, the second enzyme composition comprises xylanase XYN2 from  Trichoderma reesei.  In some embodiments, the second enzyme composition comprises xylanase XYN3 from  Trichoderma reesei.    
         [0028]    In some embodiments, the at least one xylanase has an amino acid sequence having at least 80% identity to an amino acid sequence selected from SEQ ID NO: 1 or SEQ ID NO: 2. In some embodiments, the at least one xylanase has an amino acid sequence having at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, or even at least 99% amino acid sequence identity to identity to an amino acid sequence selected from SEQ ID NO: 1 or SEQ ID NO: 2. In particular embodiments, the at least one xylanase has an amino acid sequence selected from SEQ ID NO: 1 or SEQ ID NO: 2. 
         [0029]    In some embodiments, the at least one additional hemicellulase is selected from the group consisting of a GH54 hemicellulase, a GH62 hemicellulase, a GH27 hemicellulase, a GH36 hemicellulase, a GH5 hemicellulase, a GH74 hemicellulase, a GH67 hemicellulase, a GH28 hemicellulase, a GH11 hemicellulase, a GH10 hemicellulase, a GH3 hemicellulase, and a CE5 hemicellulase. 
         [0030]    In some embodiments, the at least one additional hemicellulase is a β-xylosidase or an arabinofuranosidase. In particular embodiments, the β-xylosidase is BXL1 from  Trichoderma reesei  and the arabinofuranosidase is ABF1, ABF2, or ABF3 from  Trichoderma reesei.  In some embodiments, the at least one additional hemicellulase is a combination of a β-xylosidase and an arabinofuranosidase. 
         [0031]    In some embodiments, the first enzyme composition is a whole cellulase blend from a filamentous fungus supplemented with an addition amount of β-glucosidase, the second enzyme composition comprises xylanase, and the at least one additional hemicellulase is a combination of a β-xylosidase and arabinofuranosidase. 
         [0032]    In some embodiments, the at least one additional hemicellulase is a  Trichoderma reesei  hemicellulase selected from the group consisting of α-arabinofuranosidase I (ABF1), α-arabinofuranosidase II (ABF2), α-arabinofuranosidase III (ABF3), α-galactosidase I (AGL1), α-galactosidase II (AGL2), α-galactosidase III (AGL3), acetyl xylan esterase I (AXE1), acetyl xylan esterase III (AXE3), endoglucanase VI (EG6), endoglucanase VIII (EG8), α-glucuronidase I (GLR1), β-mannanase (MANI), polygalacturonase (PEC2), xylanase I (XYN1), xylanase II (XYN2), xylanase III (XYN3), and β-xylosidase (BXL1). 
         [0033]    In some embodiments, the at least one additional hemicellulase has an amino acid sequence having at least 80% identity to an amino acid sequence selected from the group consisting of SEQ ID NO: 3, SEQ ID NO: 4, SEQ ID NO: 5, SEQ ID NO: 6, SEQ ID NO: 7, SEQ ID NO: 8, SEQ ID NO: 9, SEQ ID NO: 10, SEQ ID NO: 11, SEQ ID NO: 12, SEQ ID NO: 13, SEQ ID NO: 14, SEQ ID NO: 15, SEQ ID NO: 16, and SEQ ID NO: 17. In some embodiments, the at least one additional hemicellulase has an amino acid sequence having at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, or even at least 99% amino acid sequence identity to one of the aforementioned amino acid sequences. In particular embodiments, the at least one additional hemicellulase has an amino acid sequence corresponding to one of aforementioned amino acid sequences. 
         [0034]    In some embodiments, contacting the mixture of cellulosic and hemicellulosic materials with the first enzyme composition, the second enzyme composition, and the third enzyme composition are performed simultaneously. 
         [0035]    In some embodiments, the first enzyme composition, the second enzyme composition, and the third enzyme composition are provided in a single composition enzyme blend. 
         [0036]    These and other aspect and embodiments of the present compositions and methods will be apparent from the following description. 
     
    
     DETAILED DESCRIPTION 
     I. Definitions 
       [0037]    Unless defined otherwise herein, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art. The headings provided herein are not limitations of the various aspects or embodiments of the invention described under one heading may apply to the compositions and methods as a whole. Both the foregoing general description and the following detailed description are exemplary and explanatory and are not restrictive of the compositions and methods described herein. The use of the singular includes the plural unless specifically stated otherwise, and the use of “or” means “and/or” unless state otherwise. The terms “comprise,” “comprising,” “comprises,” “include,” “including,” and “includes” are not intended to be limiting. All patents and publications, including all amino acid and nucleotide sequences disclosed within such patents and publications, referred to herein are expressly incorporated by reference. The following terms are defined for clarity: 
         [0038]    As used herein, the term “cellulose: refers a polysaccharide consisting of β(1→4) linked D-glucose units having the general formula (C 6 H 10 O 5 ) n . Cellulose is the structural component of the primary cell wall of green plants, many forms of algae and the oomycetes. 
         [0039]    As used herein, the term “cellulase” refers to an enzyme capable of hydrolyzing cellulose polymers to shorter oligomers and/or glucose. 
         [0040]    As used herein, the term “whole cellulase composition/preparation/mixture” or the like refers to both naturally occurring and non-naturally occurring compositions that include a plurality of cellulases produced by an organism, for example a filamentous fungus. One example of a whole cellulase composition is medium in which filamentous fungi are cultured, which includes secreted cellulases, such as one or more cellobiohydrolases, one or more endoglucanases, and one or more β-glucosidases at a predetermined ratio. 
         [0041]    As used herein, “hemicellulose” is a polymer component of plant materials that contains sugar monomers other than glucose, in contrast to cellulose, which contains only glucose. In addition to glucose, hemicellulose may include xylose, mannose, galactose, rhamnose, and arabinose, with xylose being the most common sugar monomer. Hemicelluloses contain most of the D-pentose sugars, and occasionally small amounts of L-sugars. The sugars in hemicellulose may be linked by ester linkages as well as glycosidic linkages. Exemplary forms of hemicellulose include but are not limited to are galactan, mannan, xylan, arabanan, arabinoxylan, glucomannan, galactomanan, and the like. 
         [0042]    As used herein, the term “hemicellulase” refers to a class of enzymes capable of breaking hemicellulose into its component sugars or shorter polymers, and includes endo-acting hydrolases, exo-acting hydrolases, and various esterases. 
         [0043]    As used herein, the term “xylanase” refers to a protein or polypeptide domain of a protein or polypeptide derived from a microorganism, e.g., a fungus, bacterium, or from a plant or animal, and that has the ability to catalyze cleavage of xylan at one or more of various positions of xylan&#39;s carbohydrate backbone, including branched xylans and xylooligosaccharides. Note that a xylanase is a type of hemicellulase. 
         [0044]    As used herein, a “biomass substrate” is a material containing both cellulose and hemicellulose. 
         [0045]    As used herein, a “naturally occurring” composition is one produced in nature or by an organism that occurs in nature. 
         [0046]    As used herein, a “variant” protein differ from the “parent” protein from which it is derived by the substitution, deletion, or addition of a small number of amino acid residues, for example, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, or more amino acid residues. In some cases, the parent protein is a “wild-type,” “native,” or “naturally-occurring” polypeptides. Variant proteins may be described as having a certain percentage sequence identity with a parent protein, e.g., at least 80%, at least 81%, at least 82%, at least 83%, at least 84%, at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at even at least 99%, which can be determined using any suitable software program known in the art, for example those described in CURRENT PROTOCOLS IN MOLECULAR BIOLOGY (F. M. Ausubel et al. (eds) 1987, Supplement 30, section 7.7.18). 
         [0047]    Preferred programs include the Vector NTI Advance˜ 9.0 (Invitrogen Corp. Carlsbad, Calif.), GCG Pileup program, FASTA (Pearson et al. (1988)  Proc. Natl, Acad. Sci USA  85:2444-2448), and BLAST (BLAST Manual, Altschul et al., Natl Cent. Biotechnol. Inf., Natl Lib. Med. (NCIB NLM NIH), Bethesda, Md., and Altschul et al. (1997)  NAR  25:3389-3402). Another preferred alignment program is ALIGN Plus (Scientific and Educational Software, PA), preferably using default parameters. Another sequence software program that finds use is the TFASTA Data Searching Program available in the Sequence Software Package Version 6.0 (Genetics Computer Group, University of Wisconsin, Madison, Wis.). 
       II. Bioconverting Enzyme Blend Compositions and Methods of Use, Thereof 
       [0048]    Cellulose is a homopolymer of anhydrocellobiose and thus a linear β-(1-4)-D-glucan. In contrast, hemicelluloses include a variety of compounds, such as xylans, xyloglucans, arabinoxylans, and mannans, in complex branched structures, and with a spectrum of substituents. As a consequence of the complex branching and heterogenous composition of hemicelluloses, particularly arabinoxylans, the enzymatic degradation of plant material requires the action of a battery of both debranching and depolymerizing activities. Additionally, the degradation of plant materials requires enzymes that act on hemicelluloses containing both five-carbon sugars (pentoses), such as xylose and arabinose, and six-carbon sugars (hexoses), such as mannose and glucose. 
         [0049]    Enzyme hydrolysis of hemicellulose to its monomers requires the participation of several hemicellulase enzymes with different functions. Hemicellulases can be placed into three general categories: endo-acting enzymes that attack internal bonds within the polysaccharide, exo-acting enzymes that act processively from either the reducing or nonreducing end of a polysaccharide chain, and the accessory enzymes, acetylesterases, and esterases that hydrolyze lignin glycoside bonds, such as coumaric acid esterase and ferulic acid esterase. 
         [0050]    While certain fungi produce complete cellulase systems which include exo-cellobiohydrolases (or CBH-type cellulases), endoglucanases (or EG-type cellulases), and β-glucosidases (or BG-type cellulases), known cellulase enzymes and mixtures, thereof, typically have limited activity against hemicellulose, and limited value in hydrolyzing plant materials. The present bioconverting enzyme blend compositions and methods are based, in part, on the observation that certain combinations of cellulases and hemicellulases significantly increase the efficiency of plant material hydrolysis, primarily as determined by monitoring the conversion of glucan and xylan. 
         [0051]    The exemplary cellulase composition used to identify cellulase/hemicellulase compositions that increase the hydrolysis of glucan and/or xylan is a whole cellulase compositions produced by a filamentous fungus (i.e.,  Trichoderma reesei ). The composition includes several exo-cellobiohydrolases and endoglucanases, and is supplemented with additional β-glucosidase to increase the release of glucose. This composition is commercially available as ACCELLERASE 1000™ (Danisco A/S, Genencor Division, Palo Alto, Calif.). ACCELLERASE 1000™ includes exo-cellobiohydrolases (i.e., about 50% (wt/wt) GBH! (CEL7A) and about 14% GBHII (CEL6A), endoglucanases (i.e., about 12% EGI (CEL7B) and about 10% EGII (CEL5A)), and β-glucosidase (i.e., about 5% BGLI (CEL3A). A small amount of XYN2 (i.e., less than about 1%) may also be present. Other components that are not identified are also in amounts of less than about 1%. 
         [0052]    Other cellulase compositions may be used, including other whole cellulase mixtures and cellulase mixtures assembled from multiple individually isolated cellulases. Preferred cellulase compositions include at least one each of an exo-cellobiohydrolase, an endoglucanase, and a β-glucosidase. In some embodiments, a whole broth that includes multiple cellulases is prepared from an organism such as an  Acremonium, Aspergillus, Emericella, Fusarium, Humicola, Mucor, Myceliophthora, Neurospora, Scytalidium, Thielavia, Tolypocladium, Penicillium,  or  Trichoderma  spp., or species derived therefrom. 
         [0053]    The composition further includes, at least one, and in some cases two, three, or more hemicellulases. Examples of suitable additional hemicellulases include xylanases, arabinofuranosidases, acetyl xylan esterase, glucuronidases, endo-galactanase, mannanases, endo or exo-arabinases, exo-galactanases, and mixtures thereof. Examples of suitable endo-acting hemicellulases include endo-arabinanase, endo-arabinogalactanase, endoglucanase, endo-mannanase, endo-xylanase, and feraxan endoxylanase. Examples of suitable exo-acting hemicellulases include α-L-arabinosidase, β-L-arabinosidase, α-1,2-L-fucosidase, α-D-galactosidase, β-D-galactosidase, β-D-glucosidase, β-D-glucuronidase, β-D-mannosidase, β-D-xylosidase, exo-glucosidase, exo-cellobiohydrolase, exo-mannobiohydrolase, exo-mannanase, exo-xylanase, xylan α-glucuronidase, and coniferin β-glucosidase. Examples of suitable esterases include acetyl esterases (acetyl xylan esterase, acetylgalactan esterase, acetylmannan esterase, and acetylxylan esterase) and aryl esterases (coumaric acid esterase and ferulic acid esterase). 
         [0054]    Preferably, the present compositions and methods include at least one xylanase, which is a particular type of hemicellulase that cleaves the xylan main chains of hemicellulose. Preferably, the xylanase is endo-1,4-β-xylanase (E.G. 3.2.1.8). 
         [0055]    Numerous xylanases from fungal and bacterial microorganisms have been identified and characterized (see, e.g., U.S. Pat. No. 5,437,992; Coughlin, M. P. supra; Biely, P. et al. (1993)  Proceedings of the second TRICEL symposium on Trichoderma reesei Cellulases and Other Hydrolases,  Espoo 1993; Souminen, P. and Reinikainen, T. (eds)., in  Foundation for Biotechnical and Industrial Fermentation Research  8:125-135). Three specific xylanases (XYN1, XYN2, and XYN3) have been identified in  T. reesei  (Tenkanen, et al. (1992)  Enzyme Microb. Technol.  14:566; Torronen, et al. (1992)  Bio/Technology  10:1461; and Xu, et al. (1998)  Appl. Microbiol. Biotechnol.  49:718). A fourth xylanase (XYN4) isolated from  T. reesei  is described in U.S. Pat. Nos. 6,555,335 and 6,768,001 to Saloheimo et al., entitled  Xylanase from Trichoderma reesei,  method for production thereof, and methods employing this enzyme, which is incorporated herein by reference in its entirety. 
         [0056]    Exemplary xylanases for use in the present compositions and methods are XYN2 and XYN3. Suitable variants of XYN2 and XYN3, and suitable related enzymes from other organisms, have at least 80%, at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, or even at least 99% amino acid sequence identity to of XYN2 or XYN3 (i.e., SEQ ID NOs: 1 and 2, respectively). 
         [0057]    In addition to the cellulase composition and a xylanase, the compositions and methods may include one or more additional hemicellulases, such as an endo-acting hemicellulase, an exo-acting hemicellulase, and/or an esterases. 
         [0058]    Suitable endo-acting hemicellulases include but are not limited to mannan endo-1,4-β-mannosidase (E.G. 3.2.1.78, also known as β-mannase and β-mannanase), which catalyzes the random endohydrolysis of 1,4,-β-D-mannosiic linkages in mannans, galactomannans, glucomannans; α-amylase (E.G. 3.2.1.1), which catalyzes the endohydrolysis of 1,4-α-D-glucosidic linkages in polysaccharides containing three or more 1,4-α-linked D-glucose units; xylan α-1,2-glucuronosidase (E.G. 3.2.1.131, also known as α-glucuronosidase), which catalyzes the hydrolysis of α-D-1,2-(4-O-methyl)glucuronosyl links in the main chain of hardwood xylans; and endoglucanase (E.G. 3.2.1.4), which catalyzes endohydrolysis of 1,4-β-D-glucosidc linkages in cellulase, lichenin, and cereal β-D-glucans. Multiple subtypes of endoglucanase have been identified and are suitable for use in the compositions and methods, for example, endoglucanase I, endoglucanase II, endoglucanase III, endoglucanase V, and endoglucanase VI. 
         [0059]    Suitable exo-acting hemicellulases include but are not limited to α-arabinofuranosidase, α-galactosidase, and β-xylosidase. α-arabinofuranosidase, also known as α-N-arabinofuranosidase (E.G. 3.2.1.55), catalyzes the hydrolysis of terminal non-reducing α-L-arabinofuranoside residues in α-L-arabinosides Any of the at least three known subtypes of α arabinofuranosidase (i.e., abf1, abf2 and abf3) can be used. α-galactosidase (E.G. 3.2.1.22) catalyzes the hydrolysis of terminal, non-reducing α-D-galactose residues in α-D-galactosides including galactose oligosaccharides and galactomannans. Any of the three known subtypes, i.e., α-galactosidase I (agl1), α-galactosidase II (agl2) and α-galactosidase III (agl3) can be used. Glucoamylase, also known as glucan 1,4-α-glucosidase (E.G. 3.2.1.3), catalyzes hydrolysis of terminal 1,4-linked α-D-glucose residues successively from non-reducing ends of the chains with release of β-D-glucose. β-glucosidase (E.G. 3.2.1.21) catalyzes the hydrolysis of terminal, non-reducing β-D-glucose residues with release of β-D-glucose. β-xylosidase, also known as xylan 1,4-β-xylosidase (E.G. 3.2.1.37), catalyzes hydrolysis of 1,4-β-D-xylans, to remove successive D-xylose residues from the non-reducing termini. Compositions that included a whole cellulase mixture, along with a xylanase and either an α-arabinofuranosidase or a β-xylosidase were particularly effective in glucan and/or xylan conversion. 
         [0060]    Suitable esterases include but are not limited to ferulic acid esterase and acetyl xylan esterase. Ferulic acid esterase, also known as ferulate esterase (E.G. 3.1.1.73), catalyses the hydrolysis of the 4-hydroxy-3-methoxycinnamoyl (feruloyl) group from an esterified sugar, which is usually arabinose in “natural” substrates. Known microbial ferulic acid esterases are secreted into the culture medium. Any of the three known subtypes of ferulic acid esterase (fae1, fae2, and fae3) can be used in the present compositions and methods. Acetyl xylan esterase I (E.G. 3.1.1.72) catalyzes the deacetylation of xylans and xylo-oligosaccharides, and can also be used in the compositions and methods. U.S. Pat. Nos. 5,426,043 and 5,681,732 to De Graaff et al. describe the cloning and expression of acetyl xylan esterases from fungal origin. EP 507 369 discloses a DNA sequence encoding an acetyl xylan esterase isolated from  Aspergillus niger.  U.S. Pat. No. 5,830,734 to Christgau et al., entitled Enzyme with acetyl esterase activity, describes the isolation of a variety of esterases for use in the food industry. 
         [0061]    In some embodiments, the at least one additional hemicellulase is selected from the group consisting of a GH54 hemicellulase, a GH62 hemicellulase, a GH27 hemicellulase, a GH36 hemicellulase, a GH5 hemicellulase, a GH74 hemicellulase, a GH67 hemicellulase, a GH28 hemicellulase, a GH11 hemicellulase, a GH10 hemicellulase, a GH3 hemicellulase, and a CE5 hemicellulase. In some embodiments, the at least one additional hemicellulase is selected from the group consisting of α-arabinofuranosidase I (ABF1), α-arabinofuranosidase II (ABF2), α-arabinofuranosidase III (ABF3), α-galactosidase I (AGL1), α-galactosidase II (AGL2), α-galactosidase III (AGL3), acetyl xylan esterase I (AXE1), acetyl xylan esterase III (AXE3), endoglucanase VI (EG6), endoglucanase VIII (EG8), α-glucuronidase I (GLR1), β-mannanase (MAN1), polygalacturonase (PEC2), xylanase I (XYN1), xylanase II (XYN2), xylanase III (XYN3), and β-xylosidase (BXL1), which may be from a filamentous fungus, such as  T. reesei.  In some embodiments, the at least one additional hemicellulase has an amino acid sequence having at least 80%, at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, or even at least 99% amino acid sequence identity to an amino acid sequence selected from the group consisting of SEQ ID NO: 3, SEQ ID NO: 4, SEQ ID NO: 5, SEQ ID NO: 6, SEQ ID NO: 7, SEQ ID NO: 8, SEQ ID NO: 9, SEQ ID NO: 10, SEQ ID NO: 11, SEQ ID NO: 12, SEQ ID NO: 13, SEQ ID NO: 14, SEQ ID NO: 15, SEQ ID NO: 16, and SEQ ID NO: 17. 
         [0062]    Variants of hemicellulases (including xylanases) may include substitutions, insertions, or deletions that do not substantially affect function, or add advantageous features to the enzymes. In some embodiments, the substitutions, insertions, or deletions are not in the conserved sequence motifs but are instead limited to amino acid sequences outside the conserved motifs. Exemplary substitutions are conservative substitutions, which preserve charge, hydrophobicity, or side group size relative to the parent amino acid sequence. Examples of conservative substitutions are provided in the following Table: 
         [0000]    
       
         
               
               
               
             
           
               
                   
               
               
                 Original 
                   
                   
               
               
                 Amino Acid 
               
               
                 Residue 
                 Code 
                 Acceptable Substitutions 
               
               
                   
               
             
             
               
                 Alanine 
                 A 
                 D-Ala, Gly, beta-Ala, L-Cys, D-Cys 
               
               
                 Arginine 
                 R 
                 D-Arg, Lys, D-Lys, homo-Arg, D-homo-Arg, 
               
               
                   
                   
                 Met, Ile, D-Met, D-Ile, Orn, D-Orn 
               
               
                 Asparagine 
                 N 
                 D-Asn, Asp, D-Asp, Glu, D-Glu, Gln, D-Gln 
               
               
                 Aspartic Acid 
                 D 
                 D-Asp, D-Asn, Asn, Glu, D-Glu, Gln, D-Gln 
               
               
                 Cysteine 
                 C 
                 D-Cys, S-Me-Cys, Met, D-Met, Thr, D-Thr 
               
               
                 Glutamine 
                 Q 
                 D-Gln, Asn, D-Asn, Glu, D-Glu, Asp, D-Asp 
               
               
                 Glutamic Acid 
                 E 
                 D-Glu, D-Asp, Asp, Asn, D-Asn, Gln, D-Gln 
               
               
                 Glycine 
                 G 
                 Ala, D-Ala, Pro, D-Pro, b-Ala, Acp 
               
               
                 Isoleucine 
                 I 
                 D-Ile, Val, D-Val, Leu, D-Leu, Met, D-Met 
               
               
                 Leucine 
                 L 
                 D-Leu, Val, D-Val, Leu, D-Leu, Met, D-Met 
               
               
                 Lysine 
                 K 
                 D-Lys, Arg, D-Arg, homo-Arg, D-homo-Arg, 
               
               
                   
                   
                 Met, D-Met, Ile, D-Ile, Orn, D-Orn 
               
               
                 Methionine 
                 M 
                 D-Met, S-Me-Cys, Ile, D-Ile, Leu, D-Leu, Val, 
               
               
                   
                   
                 D-Val 
               
               
                 Phenylalanine 
                 F 
                 D-Phe, Tyr, D-Thr, L-Dopa, His, D-His, Trp, 
               
               
                   
                   
                 D-Trp, Trans-3,4, or 5-phenylproline, cis-3,4, 
               
               
                   
                   
                 or 5-phenylproline 
               
               
                 Proline 
                 P 
                 D-Pro, L-l-thioazolidine-4- carboxylic acid, 
               
               
                   
                   
                 D-or L-1-oxazolidine-4-carboxylic acid 
               
               
                 Serine 
                 S 
                 D-Ser, Thr, D-Thr, allo-Thr, Met, D-Met, 
               
               
                   
                   
                 Met(O), D-Met(O), L-Cys, D-Cys 
               
               
                 Threonine 
                 T 
                 D-Thr, Ser, D-Ser, allo-Thr, Met, 
               
               
                   
                   
                 D-Met, Met(O), D-Met(O), Val, D-Val 
               
               
                 Tyrosine 
                 Y 
                 D-Tyr, Phe, D-Phe, L-Dopa, His, D-His 
               
               
                 Valine 
                 V 
                 D-Val, Leu, D-Leu, Ile, D-Ile, Met, D-Met 
               
               
                   
               
             
          
         
       
     
         [0063]    It will be apparent that naturally occurring amino acids can be introduced into a polypeptide by changing the coding sequence of the nucleic acid encoding the polypeptide, while non-naturally-occurring amino acids are typically produced by chemically modifying an expressed polypeptide. 
         [0064]    Further accessory enzymes, such as laccase (E.G. 1.10.3.2), which catalyzes oxidation of aromatic compounds, and consequent reduction of oxygen to water, can also be included in the bioconverting enzyme blends of the present compositions and methods. 
         [0065]    In some embodiments, enzymes for use in the present bioconverting enzyme blends can be prepared from one or more strains of filamentous fungi. Suitable filamentous fungi include members of the subdivision Eumycota and Oomycota, including but are not limited to the following genera:  Aspergillus, Acremonium, Aureobasidium, Beauveria, Cephalosporium, Ceriporiopsis, Chaetomium, Chrysosporium, Claviceps, Cochiobolus, Cryptococcus, Cyathus, Endothia, Endothia mucor, Fusarium, Gilocladium, Humicola, Magnaporthe, Myceliophthora, Myrothecium, Mucor, Neurospora, Phanerochaete, Podospora, Paecilomyces, Pyricularia, Rhizomucor, Rhizopus, Schizophylum, Stagonospora, Talaromyces, Trichoderma, Thermomyces, Thermoascus, Thielavia, Tolypocladium, Trichophyton,  and  Trametes.  In some embodiments, the filamentous fungi include, but are not limited to the following:  A. nidulans, A. niger, A. awomari, A. aculeatus, A. kawachi  e.g., NRRL 3112, ATCC 22342 (NRRL 3112), ATCC 44733, ATCC 14331 and strain UVK 143f,  A. oryzae,  e.g., ATCC 11490,  N. crassa, Trichoderma reesei,  e.g., NRRL 15709, ATCC 13631, 56764, 56765, 56466, 56767, and  Trichoderma viride,  e.g., ATCC 32098 and 32086. In a preferred implementation, the filamentous fungi is a  Trichoderma  species. A particularly preferred species and strain for use in the present invention is  T. reesei  RL-P37. 
         [0066]    In a particular embodiment, a single engineered strain overexpresses the component enzymes at the desired ratio so that no additional purification or supplementation is necessary. In an alternative embodiment, the bioconverting enzyme blend is obtained from two or more naturally occurring or engineered strains of filamentous fungi. The desired ratio of the component enzymes can be achieved by altering the relative amount of enzyme in the final blend. Even when two or more production strains are use, the desired ratio of component enzymes may be achieved by supplementation with purified or partially purified enzyme. 
         [0067]    In particular embodiments, a hemicellulase is prepared from  Aspergillus aculeatus, Aspergillus awarnori, Aspergillus foetidus, Aspergillus japonicus, Aspergillus nidulans, Aspergillus niger,  or  Aspergillus oryzae.  In another aspect, whole broth is prepared from  Fusarium bactridioides, Fusarium cerealis, Fusarium crookwellense, Fusarium culmorum, Fusarium graminearum, Fusarium graminum, Fusarium heterosporum, Fusarium negundi, Fusarium oxysporum, Fusarium reticulatum, Fusarium roseum, Fusarium sambucinum, Fusarium sarcochroum, Fusarium sporotrichioides, Fusarium sulphureum, Fusarium torulosum, Fusarium trichothecioides, Fusarium venenatum  or  Fusarium verticilloides.  In another aspect, the hemicellulase complex is prepared from a  Humicola insolens, Humicola lanuginosa, Mucor miehei, Myceliophthora thermophila, Neurospora crassa, Scytalidium thermophilum,  or  Thielavia terrestris.  In other embodiments, a hemicellulase is prepared from a  Trichoderma harzianum, Trichoderma koningii, Trichoderma longibrachiatum, Trichoderma reesei,  e.g., RL-P37 [Sheir-Neiss et al. (1984)  Appl. Microbiol. Biotechnology  20:46-53; U.S. Pat. No. 4,797,361; available as a biologically pure culture from the permanent collection of the Northern Regional Research Laboratory, U.S. Department of Agriculture, Peoria, Ill., U.S.A. (NRRL 15709); ATCC 13631, 56764, 56466, 56767], or  Trichoderma viride  e.g., ATCC 32098 and 32086. 
         [0068]    In some embodiments, a component hemicellulase enzyme is produced by expressing a gene encoding the hemicellulase enzyme. For example, xylanase can be secreted into the extracellular space of, e.g., a Gram-positive organism, such as  Bacillus  or  Actinomycetes,  or a eukaryotic organism, such as  Trichoderma, Aspergillus, Saccharomyces,  or  Pichia.  It is to be understood, that in some embodiments, one or more hemicellulase enzymes can be over-expressed in a recombinant microorganism relative to the native levels. The host cell may be genetically modified to reduce expression of one or more proteins that are endogenous to the cell. In one embodiment, the cell may contain one or more native genes, particularly genes that encode secreted proteins that have been deleted or inactivated. For example, one or more protease-encoding genes (e.g., an aspartyl protease-encoding gene; see Berka et al. (1990)  Gene  86:153-162 and U.S. Pat. No. 6,509,171), or cellulase-encoding genes, may be deleted or inactivated. The nucleic acids encoding the hemicellulase may be present in the genome of an organism or carried in a plasmid that replicates in the organism. Where the hemicellulase is expressed from the genome, the gene and regulator sequences associate therewith, can be introduced into the genome by random or homologous integration. In certain cases, e.g., when a particularly high level of expression is desired, both random and homologous integration can be used. 
         [0069]    The biomass substrate for use as a source of cellulose and hemicellulose for hydrolysis using the present enzyme compositions and methods can be, e.g., herbaceous material, agricultural residues, forestry residues, municipal solid waste, waste paper, and pulp and paper residues, and the like. Common forms of biomass substrate include, but are not limited to trees, shrubs and grasses, wheat, wheat straw, sugar cane bagasse, corn, corn husks, corn kernel including fiber from kernels, products and by-products from milling of grains such as corn (including wet milling and dry milling) as well as municipal solid waste, waste paper and yard waste. The biomass substrate may be obtained from “virgin biomass” (such as trees, bushes, grasses, fruits, flowers, herbaceous crops, hard and soft woods.), “non-virgin biomass” (such as agricultural byproducts, commercial organic waste, construction and demolition debris, municipal solid waste and yard waste), or “blended biomass,” which is a mixture of virgin and non-virgin biomass. The biomass substrate may include, e.g., wood, wood pulp, papermaking sludge, paper pulp waste streams, particle board, corn stover, corn fiber, rice, paper and pulp processing waste, woody or herbaceous plants, fruit pulp, vegetable pulp, pumice, distillers grain, grasses, rice hulls, sugar cane bagasse, cotton, jute, hemp, flax, bamboo, sisal, abaca, straw, corn cobs, distillers grains, leaves, wheat straw, coconut hair, algae, switchgrass, and mixtures thereof. 
         [0070]    The biomass substrate can be used directly or may be subjected to pretreatment using conventional methods known in the art. Such pretreatments include chemical, physical, and biological pretreatments. For example, physical pretreatment techniques include, without limitation, various types of milling, crushing, steaming/steam explosion, irradiation and hydrothermolysis. Chemical pretreatment techniques include, without limitation, dilute acid, alkaline agents, organic solvents, ammonia, sulfur dioxide, carbon dioxide, and pH-controlled hydrothermolysis. Biological pretreatment techniques include, without limitation, applying lignin-solubilizing microorganisms. 
         [0071]    Optimum dosage levels of bioconverting enzyme blend, and cellulases and hemicellulases, therein, vary depending on the biomass substrate and the pretreatment technologies used. Operating conditions such as pH, temperature and reaction time may also affect rates of ethanol production. Preferably, the reactive composition contains 0.1 to 200 mg bioconverting enzyme blend per gram of biomass, more preferably 1 to 100 mg bioconverting enzyme blend per gram of biomass and most preferably 10-50 mg bioconverting enzyme blend per gram of biomass. Exemplary amounts are 0.1-50, 1-40, 20-40, 1-30, 2-40, and 10-20 mg bioconverting enzyme blend per gram of biomass. Alternatively, the amount of enzyme can be determined based on the amount of substrate in the system. In such a case, the reactive composition preferably contains 0.1 to 50 mg bioconverting enzyme blend per gram of total saccharides, more preferably, 1 to 30 mg bioconverting enzyme blend per gram of total saccharides, and more preferably 10 to 20 mg bioconverting enzyme blend per gram of total saccharides. Alternatively, the amount of enzyme can be determined based on the amount of cellulose substrate in the system. In such a case, the reactive composition preferably contains 0.2 to 100 mg bioconverting enzyme blend per gram of total glucan, more preferably, 2 to 60 mg bioconverting enzyme blend per gram of total glucan, and more preferably 20 to 40 mg bioconverting enzyme blend per gram of total glucan. Similarly, the amount of bioconverting enzyme blend utilized can be determined by the amount of hemicellulose in the substrate biomass. Accordingly, the reactive composition preferably contains 0.2 to 100 mg bioconverting enzyme blend per gram of hemicellulose, more preferably, 2 to 60 mg bioconverting enzyme blend per gram of hemicellulose, and more preferably 20 to 40 mg bioconverting enzyme blend per gram of hemicellulose. 
         [0072]    In some embodiments, the present composition is in the form of a hemicellulose-enhanced whole cellulase composition, comprising a whole cellulase preparation and at least one hemicellulase, wherein the amount of hemicellulase is in the range of 1% to 50% of the total protein and the whole cellulase is in the range of less than 99% to 50% of total protein. For example, the hemicellulase may represent 1% of the total protein and the whole cellulase composition may represent 99% of the total protein, the hemicellulase may represent 2% of the total protein and the whole cellulase composition may represent 98% of the total protein, the hemicellulase may represent 3% of the total protein and the whole cellulase composition may represent 97% of the total protein, the hemicellulase may represent 4% of the total protein and the whole cellulase composition may represent 96% of the total protein, the hemicellulase may represent 5% of the total protein and the whole cellulase composition may represent 95% of the total protein, the hemicellulase may represent 6% of the total protein and the whole cellulase composition may represent 94% of the total protein, the hemicellulase may represent 7% of the total protein and the whole cellulase composition may represent 93% of the total protein, the hemicellulase may represent 8% of the total protein and the whole cellulase composition may represent 92% of the total protein, the hemicellulase may represent 9% of the total protein and the whole cellulase composition may represent 91% of the total protein, the hemicellulase may represent 10% of the total protein and the whole cellulase composition may represent 90% of the total protein, the hemicellulase may represent 11% of the total protein and the whole cellulase composition may represent 89% of the total protein, the hemicellulase may represent 12% of the total protein and the whole cellulase composition may represent 88% of the total protein, the hemicellulase may represent 13% of the total protein and the whole cellulase composition may represent 87% of the total protein, the hemicellulase may represent 14% of the total protein and the whole cellulase composition may represent 86% of the total protein, the hemicellulase may represent 15% of the total protein and the whole cellulase composition may represent 85% of the total protein, the hemicellulase may represent 16% of the total protein and the whole cellulase composition may represent 84% of the total protein, the hemicellulase may represent 17% of the total protein and the whole cellulase composition may represent 83% of the total protein, the hemicellulase may represent 18% of the total protein and the whole cellulase composition may represent 82% of the total protein, the hemicellulase may represent 19% of the total protein and the whole cellulase composition may represent 81% of the total protein, the hemicellulase may represent 20% of the total protein and the whole cellulase composition may represent 80% of the total protein, the hemicellulase may represent 21% of the total protein and the whole cellulase composition may represent 79% of the total protein, the hemicellulase may represent 22% of the total protein and the whole cellulase composition may represent 78% of the total protein, the hemicellulase may represent 23% of the total protein and the whole cellulase composition may represent 77% of the total protein, the hemicellulase may represent 24% of the total protein and the whole cellulase composition may represent 76% of the total protein, the hemicellulase may represent 25% of the total protein and the whole cellulase composition may represent 75% of the total protein, the hemicellulase may represent 26% of the total protein and the whole cellulase composition may represent 74% of the total protein, the hemicellulase may represent 27% of the total protein and the whole cellulase composition may represent 73% of the total protein, the hemicellulase may represent 28% of the total protein and the whole cellulase composition may represent 72% of the total protein, the hemicellulase may represent 29% of the total protein and the whole cellulase composition may represent 71% of the total protein, the hemicellulase may represent 30% of the total protein and the whole cellulase composition may represent 70% of the total protein, the hemicellulase may represent 31% of the total protein and the whole cellulase composition may represent 69% of the total protein, the hemicellulase may represent 32% of the total protein and the whole cellulase composition may represent 68% of the total protein, the hemicellulase may represent 33% of the total protein and the whole cellulase composition may represent 67% of the total protein, the hemicellulase may represent 34% of the total protein and the whole cellulase composition may represent 66% of the total protein, the hemicellulase may represent 35% of the total protein and the whole cellulase composition may represent 65% of the total protein, the hemicellulase may represent 36% of the total protein and the whole cellulase composition may represent 64% of the total protein, the hemicellulase may represent 37% of the total protein and the whole cellulase composition may represent 63% of the total protein, the hemicellulase may represent 38% of the total protein and the whole cellulase composition may represent 62% of the total protein, the hemicellulase may represent 39% of the total protein and the whole cellulase composition may represent 61% of the total protein, the hemicellulase may represent 40% of the total protein and the whole cellulase composition may represent 60% of the total protein, the hemicellulase may represent 41% of the total protein and the whole cellulase composition may represent 59% of the total protein, the hemicellulase may represent 42% of the total protein and the whole cellulase composition may represent 58% of the total protein, the hemicellulase may represent 43% of the total protein and the whole cellulase composition may represent 57% of the total protein, the hemicellulase may represent 44% of the total protein and the whole cellulase composition may represent 56% of the total protein, the hemicellulase may represent 45% of the total protein and the whole cellulase composition may represent 55% of the total protein, the hemicellulase may represent 46% of the total protein and the whole cellulase composition may represent 54% of the total protein, the hemicellulase may represent 47% of the total protein and the whole cellulase composition may represent 53% of the total protein, the hemicellulase may represent 48% of the total protein and the whole cellulase composition may represent 52% of the total protein, the hemicellulase may represent 49% of the total protein and the whole cellulase composition may represent 51% of the total protein, or the hemicellulase may represent 50% of the total protein and the whole cellulase composition may represent 50% of the total protein. 
         [0073]    In use, the bioconverting enzyme blend compositions may be added to a suitable substrate material individually, i.e., as separate enzyme compositions, or as a single enzyme mixtures in which all cellulases and hemicellulases are present prior to addition to the substrate. Where the cellulases and hemicellulases are separate enzyme compositions, they may be added sequentially or simultaneously to the substrate. Where the cellulases and hemicellulases are present in a single mixture, they are added simultaneously. 
         [0074]    Other aspects and embodiments of the compositions and method may be further understood in view of the following examples, which should not be construed as limiting. It will be apparent to those skilled in the art that many modifications, both to materials and methods, may be made without departing from the present teachings. 
       EXAMPLES  
       [0075]    ACCELLERASE 1000™ (Danisco N S, Genencor Division, Palo Alto, Calif.), a whole broth of killed cellular material that includes a  T. reesei  whole cellulase mixture supplemented with  T. reesei  BGLU1 [3-glucosidase, was used as source of cellulases. MULTIFECT® Xylanase (Danisco N S, Genencor Division, Palo Alto, Calif.), a xylanase II, high pl, formulated product, was used as a source of XYN2. 
         [0076]      T. reesei  hemicellulases were individually over-expressed in a strain of  T. reesei  in which the genes encoding CBHI, CBHII, EG1, and EG2 were deleted, to avoid the presence of these cellulases in the resulting cellular material (e.g., conditioned media or “broths”). Hemicellulases of interest ranged from &lt;10% to 85% of total protein in these broths. In many cases, the broths were used directly; however, several hemicellulases were further purified to demonstrate that the observed activities were not the result of other protein present in the broth. 
         [0077]    The acronyms, polypeptide SEQ ID NOs, and Carbohydrate-Active enZymes (CAZY) family and clan designations (where known) of the particular enzymes are provided in Table 1. The aforementioned XYN2 polypeptide has the amino acid sequence of SEQ ID NO: 1 and is a family GH11 Clan C enzyme. The amino acid sequences of the immature polypeptides are also shown, below. 
         [0000]    
       
         
               
               
               
               
               
             
               
               
               
               
               
             
           
               
                 TABLE 1 
               
               
                   
               
               
                 Acronym 
                 Enzyme 
                 SEQ ID 
                 Family 
                 Clan 
               
               
                   
               
             
             
               
                   
               
             
          
           
               
                 ABF1 
                 α-arabinofuranosidase I 
                 3 
                 GH54 
                   
               
               
                 ABF2 
                 α-arabinofuranosidase II 
                 4 
                 GH62 
                 F 
               
               
                 ABF3 
                 α-arabinofuranosidase III 
                 5 
                 GH54 
               
               
                 AGL1 
                 α-galactosidase I 
                 6 
                 GH27 
                 D 
               
               
                 AGL2 
                 α-galactosidase II 
                 7 
                 GH36 
                 D 
               
               
                 AGL3 
                 α-galactosidase III 
                 8 
                 GH27 
                 D 
               
               
                 AXE1 
                 acetyl xylan esterase I 
                 9 
                 CE5 
               
               
                 AXE3 
                 acetyl xylan esterase III 
                 10 
                 CE5 
               
               
                 EG6 
                 endoglucanase VI 
                 11 
                 GH74 
               
               
                 EG8 
                 endoglucanase VIII 
                 12 
                 GH5 
                 A 
               
               
                 GLR1 
                 α-glucuronidase I 
                 13 
                 GH67 
               
               
                 MAN1 
                 β-mannanase 
                 14 
                 GH5 
                 A 
               
               
                 PEC2 
                 polygalacturonase 
                 15 
                 GH28 
                 N 
               
               
                 XYN1 
                 xylanase I 
                 16 
                 GH11 
                 C 
               
               
                 XYN3 
                 xylanase III 
                 2 
                 GH10 
                 A 
               
               
                 BXL1 
                 β-xylosidase 
                 17 
                 GH3 
               
               
                   
               
             
          
         
       
     
         [0000]    
       
         
               
               
             
           
               
                 XYN2 
                   
               
               
                 (SEQ ID NO: 1) 
                   
               
               
                 MVSFTSLLAASPPSRASCRPAAEVESVAVEKRQTIQPGTGYNNGYFYSYWNDGHGGVTYTNGPGGQFSVNWSNSG 
                   
               
               
                   
               
               
                 NFVGGKGWQPGTKNKVINFSGSYNPNGNSYLSVYGWSRNPLIEYYIVENFGTYNPSTGATKLGEVTSDGSVYDIY 
               
               
                   
               
               
                 RTQRVNQPSIIGTATFYQYWSVRRNHRSSGSVNTANHFNAWAQQGLTLGTMDYQIVAVEGYFSSGSASITVS 
               
               
                   
               
               
                 XYN3 
               
               
                 (SEQ ID NO: 2) 
                   
               
               
                 MKANVILCLLAPLVAALPTETIHLDPELAALRANLTERTADLWDRQASQSIDQLIKRKGKLYFGTATDRGLLQRE 
                   
               
               
                   
               
               
                 KNAAIIQADLGQVTPENSMKWQSLENNQGQLNWGDADYLVNFAQQNGKSIRGHTLIWHSQLPAWVNNINNADTLR 
               
               
                   
               
               
                 QVIRTHVSTVVGRYKGKIRAWDVVNEIFNEDGTLRSSVFSRLLGEEFVSIAFRAARDADPSARLYINDYNLDRAN 
               
               
                   
               
               
                 YGKVNGLKTYVSKWISQGVPIDGIGSQSHLSGGGGSGTLGALQQLATVPVTELAITELDIQGAPTTDYTQVVQAC 
               
               
                   
               
               
                 LSVSKCVGITVWGISDKDSWRASTNPLLFDANFNPKPAYNSIVGILQ 
               
               
                   
               
               
                 ABF1 
               
               
                 (SEQ ID NO: 3) 
                   
               
               
                 MLSNARIIAAGCIAAGSLVAAGPCDIYSSGGTPCVAAHSTTRALFSAYTGPLYQVKRGSDGATTAISPLSSGVAN 
                   
               
               
                   
               
               
                 AAAQDAFCAGTTCLITIIYDQSGRGNHLTQAPPGGFSGPESNGYDNLASAIGAPVTLNGQKAYGVFVSPGTGYRN 
               
               
                   
               
               
                 NAASGTAKGDAAEGMYAVLDGTHYNGACCFDYGNAETNSRDTGNGHMEAIYFGDSTVWGTGSGKGPWIMADLENG 
               
               
                   
               
               
                 LFSGSSPGNNAGDPSISYRFVTAAIKGQPNQWAIRGGNAASGSLSTFYSGARPQVSGYNPMSKEGAIILGIGGDN 
               
               
                   
               
               
                 SNGAQGTFYEGVMTSGYPSDATENSVQANIVAARYAVAPLTSGPALTVGSSISLRATTACCTTRYIAHSGSTVNT 
               
               
                   
               
               
                 QVVSSSSATALKQQASWTVRAGLANNACFSFESRDTSGSYIRHSNFGLVLNANDGSKLFAEDATFCTQAGINGQG 
               
               
                   
               
               
                 SSIRSWSYPTRYFRHYNNTLYIASNGGVHVFDATAAFNDDVSFVVSGGFA 
               
               
                   
               
               
                 ABF2 
               
               
                 (SEQ ID NO: 4) 
                   
               
               
                 MELKALSAVVLSFVTLVAAAPATCTLPSTYRWNSTGALASPKSGWVSLKDFSHVIYNGQHLVWGSTHDTGTIWGS 
                   
               
               
                   
               
               
                 MNFGLFSDWSNMATASQNKMTPGTVAPTVFYFAPKNIWVLAYQWGPTTFSYLTSSNPSSVNGWSSPQPLFSGSIS 
               
               
                   
               
               
                 GSSPLDQTVIGDSTNMYLFFAGDDGKIYRASMPIGNFPGSFGSTSTVVLSDERNNLFEAVQVYTVSGQKQYLMIV 
               
               
                   
               
               
                 EAIGANGRYFRSFTATNLGGTWTPQATSESQPFAGKANSGATWTNDISHGDLIRSNPDQTMTIDPCNLQFLYQG 
               
               
                   
               
               
                 RATNSGGDYGLLPYRPGLLTLQR 
               
               
                   
               
               
                 ABF3 
               
               
                 (SEQ ID NO: 5) 
                   
               
               
                 MSPRTDRRRSGLLALGLVAASPLATAGPCDIYASGGTPCVAAHSTTRALYGAYSGPLYQVSRGSDGATTNIATLS 
                   
               
               
                   
               
               
                 AGGVANAAAQDSFCAGTTCLITVIYDQSGRGNHLTQAPPGGAASGPQPNGYDNLASAIGAPVRLNGQKAYGVFIA 
               
               
                   
               
               
                 PFTGYRNNQPNGTATGDQPQGMYAIFDGTHYNTGCCFDYGNAETNSLDTGNGHMEAIYFGTGDGSGRGTGSGSGP 
               
               
                   
               
               
                 WIMADLENGLFSGYDPINNPADPTINFRFVTAVVKGEPGQWAIRGGDATSGTLSTFYSGQRPANGYNPMSKEGAI 
               
               
                   
               
               
                 ILGIGGDNSNRAQGTFYEGVMTSGYPSDSTENAVQANLVAAKYVYDTSLMTSGPALSVGSSISLRATTSCCTNRY 
               
               
                   
               
               
                 IAHTGATVNTQVVSSSSSTALKQQASWTVRTGLGNSACFSFESRDSPGSFIRHSNYQLMVNANDNSKLFHEDATF 
               
               
                   
               
               
                 CPQAGLNGQGNSFRSWSYPTRYWRHFNSLGYIAANGGEHDFDTTTLFNDDVSFVVSAGFA 
               
               
                   
               
               
                 AGL1 
               
               
                 (SEQ ID NO: 6) 
                   
               
               
                 MTPHSIDRAARPSVWSGLALLLSTAHAIVMPDGVTGKVPSLGWNSWNAYHCDIDESKFLSAAEVIVSSGLLDAGY 
                   
               
               
                   
               
               
                 NYVNIDDCWSMKDGRVDGHIAVNTTRFPDGIDGLAKKVHDLGLKLGIYSTAGTATCAGYPASLGYEDVDAADFAD 
               
               
                   
               
               
                 WGVDYLKYDNCNVPSDWQDEYVACAPDAVQTGPNGTCSTALEPNLAPPGYDWSTSKSAERFNAMRNALAKQSREI 
               
               
                   
               
               
                 VLSLCIWGVADVFSWGNETGISWRMSGDISPEWGSVTHIINMNSFKMNSVGFWGHNDADILEVGNGNLTAAETRT 
               
               
                   
               
               
                 HFALWAAMKSPLLIGTDLAQLSQENIELLKNKHLLAFNQDSVYGQPATPYKWGVNPDWTFNYTNPAEYWAGPSSK 
               
               
                   
               
               
                 GHLVLMMNTLDHTVRKEAKWSEIPGLSAGRYEVRDVWTDKSLGCLSSYKTAVAAHDTAVILVGKKCRNW 
               
               
                   
               
               
                 AGL2 
               
               
                 (SEQ ID NO: 7) 
                   
               
               
                 MLGAPSPRRLADVLAVTAGLVASVRAASPISVSGKSFALNGDNVSYRFHVDDDSKDLIGDHFGGPATEDGVFPPI 
                   
               
               
                   
               
               
                 IGPIQGWVDLIGRQRREFPDLGRGDFRTPAVHIRQAAGYTVSDFQYKSHRVVEGKPALRGLPSTFGDAGDVSTLV 
               
               
                   
               
               
                 VHMYDNYSSVAADLTYSIFPKYDAIVRSVNITNMGKGNITIEKLASLSVDLPYEDFDMLELKGDWAREGKRLRRK 
               
               
                   
               
               
                 VDYGSQGFGSTTGYSSHLHNPFFSLITPTTTESQGEAWGFSLVYTGSFSVEVEKGSQGLTRAAIGVNPYQLSWPL 
               
               
                   
               
               
                 GPGETFSSPEAVAVFSTTGVGGMSRKFHNLYRKHLIKSKFATQMHPVLLNSWEGLGFDYNDTTILHLAQESADLG 
               
               
                   
               
               
                 IKLFVLDDGWFGVKHPRVSDNAGLGDWEANPKRFPQGLPDFISDVTKLKVANSSDHLQFGLWFEPEMVNPNSTLY 
               
               
                   
               
               
                 MEHPDWAIHAGSYPRTLTRNQLVLNVALPEVQDFIIESLSNILSNASISYVKWDNNRGIHEAPYPGLDYAYMLGL 
               
               
                   
               
               
                 YRVFDTLSSKFPNVRWEGCASGGGRFDPGVLQYFPHIWTSDDTDAVERIAIQFGTSLVYPPSAMGAHVSAVPNGQ 
               
               
                   
               
               
                 TQRTTSIAFRAHVAMMGGSFGFELTPAEMPEDDKAQIPGIIALAEKVNPIVVKGDMWRLSLPEESNWPAALFISQ 
               
               
                   
               
               
                 DGSQAVLFYFQIRANINNAWPVLRLQGLDASAKYKIDGNQTFSGATLMNIGLQYQFNGDYDSKVVFLEKQT 
               
               
                   
               
               
                 AGL3 
               
               
                 (SEQ ID NO: 8) 
                   
               
               
                 MSPSAAVLIPLAAAVLLRPVVGQTQCGGNLYTPGTLNFTLECYNAFQDCVAQFEANASQVDCNDGKGNLFMQQQA 
                   
               
               
                   
               
               
                 NLGASPGSQNNDAIIAFQDIRDLCLLSGSTTATWGYSDNQWYWAAAEDACYTNDPTRTDVVKTHPAPFCIQNRDS 
               
               
                   
               
               
                 SLPECYPQPDATPPGGPLKVIKTAKTRNGFKSSARGWNTYGVQALVNGSQWPSFAGQSGLFYTQKFVETQCGVLA 
               
               
                   
               
               
                 RPEFKKAGYDLCSLDSGWQATTAVDQHGRIIYNTTRFNLPELASWLHKRDLKLGVYITPGVPCLAHNQTILGTNI 
               
               
                   
               
               
                 KIKDVLNGNNDQINCDFDFRKDGVQQWHDSVVAQWASWGVDMLKLDFLTPGSPSNGANLACDSSDAVRAYQKAIK 
               
               
                   
               
               
                 KSGRKIRLDISWKLCRNETWLPIWSDLAESMRTDQDLDNYGTNTLMAWQVGQRAIENYRQYIGLQAQRNVPLTIY 
               
               
                   
               
               
                 PDMDALFTVNPEHLAGVNDTIRYTVQNHWLGAGANLIIGGDMEQVDALGLKLTTSKQSIDAADFFAKYPMQPRNP 
               
               
                   
               
               
                 GTGSNAAKQLQAWIGGPSDDHEAYVLIVNYGPDLGNGGFSTKLYGKQKVTVSLKDLGISGSAWTFTDIWSGKSSR 
               
               
                   
               
               
                 VTGSYSAWLTEGESQLLRLKRTH 
               
               
                   
               
               
                 AXE1 
               
               
                 (SEQ ID NO: 9) 
                   
               
               
                 MPSVKETLTLLLSQAFLATGSPVDGETVVKRQCPAIHVFGARETTVSQGYGSSATVVNLVIQAHPGTTSEAIVYP 
                   
               
               
                   
               
               
                 ACGGQASCGGISYANSVVNGTNAAAAAINNFHNSCPDTQLVLVGYSQGAQIFDNALCGGGDPGEGITNTAVPLTA 
               
               
                   
               
               
                 GAVSAVKAAIFMGDPRNIHGLPYNVGTCTTQGFDARPAGFVCPSASKIKSYCDAADPYCCTGNDPNVHQGYGQEY 
               
               
                   
               
               
                 GQQALAFINSQLSSGGSQPPGGGPTSTSRPTSTRTGSSPGPTQTHWGQCGGQGWTGPTQCESGTTCQVISQWYSQ 
               
               
                   
               
               
                 CL 
               
               
                   
               
               
                 AXE3 
               
               
                 (SEQ ID NO: 10) 
                   
               
               
                 MPSIKSTVTFLLSQALLATATPMDLEKRQCPGIHVFGARETTAPPGYGSSATVVNLIINAHPGTTAEAINYPACG 
                   
               
               
                   
               
               
                 GQAQCGGISYANSVVAGINAVVQAVTNFHNRCPSTKLVLVGYSQGGQIMDDALCGGGDPAEGYPNTAVPLPAAAV 
               
               
                   
               
               
                 SAIRAAIFMGDPRYVHGLAYNVGSCQAQGFAPRNVGFVCPSGNKIKSYCDASDPYCCNGNNANTHQGYGQEYGQQ 
               
               
                   
               
               
                 ALAFVNSLLG 
               
               
                   
               
               
                 EG6 
               
               
                 (SEQ ID NO: 11) 
                   
               
               
                 MKVSRVLALVLGAVIPAHAAFSWKNVKLGGGGGFVPGIIFHPKTKGVAYARTDIGGLYRLNADDSWTAVTDGIAD 
                   
               
               
                   
               
               
                 NAGWHNWGIDAVALDPQDDQKVYAAVGMYTNSWDPSNGAIIRSSDRGATWSFTNLPFKVGGNMPGRGAGERLAVD 
               
               
                   
               
               
                 PANSNIIYFGARSGNGLWKSTDGGVTFSKVSSFTATGTYIPDPSDSNGYNSDKQGLMWVTFDSTSSTTGGATSRI 
               
               
                   
               
               
                 FVGTADNITASVYVSTNAGSTWSAVPGQPGKYFPHKAKLQPAEKALYLTYSDGTGPYDGTLGSVWRYDIAGGTWK 
               
               
                   
               
               
                 DITPVSGSDLYFGFGGLGLDLQKPGTLVVASLNSWWPDAQLFRSTDSGTTWSPIWAWASYPTETYYYSISTPKAP 
               
               
                   
               
               
                 WIKNNFIDVTSESPSDGLIKRLGWMIESLEIDPTDSNHWLYGTGMTIFGGHDLTNWDTRHNVSIQSLADGIEEFS 
               
               
                   
               
               
                 VQDLASAPGGSELLAAVGDDNGFTFASRNDLGTSPQTVWATPTWATSTSVDYAGNSVKSVVRVGNTAGTQQVAIS 
               
               
                   
               
               
                 SDGGATWSIDYAADTSMNGGTVAYSADGDTILWSTASSGVQRSQFQGSFASVSSLPAGAVIASDKKTNSVFYAGS 
               
               
                   
               
               
                 GSTFYVSKDTGSSFTRGPKLGSAGTIRDIAAHPTTAGTLYVSTDVGIFRSTDSGTTFGQVSTALTNTYQIALGVG 
               
               
                   
               
               
                 SGSNWNLYAFGTGPSGARLYASGDSGASWTDIQGSQGFGSIDSTKVAGSGSTAGQVYVGTNGRGVFYAQGTVGGG 
               
               
                   
               
               
                 TGGTSSSTKQSSSSTSSASSSTTLRSSVVSTTRASTVTSSRTSSAAGPTGSGVAGHYAQCGGIGWTGPTQCVAPY 
               
               
                   
               
               
                 VCQKQNDYYYQCV 
               
               
                   
               
               
                 EG8 
               
               
                 (SEQ ID NO: 12) 
                   
               
               
                 MRATSLLAAALAVAGDALAGKIKYLGVAIPGIDFGCDIDGSCPTDTSSVPLLSYKGGDGAGQMKHFAEDDGLNVF 
                   
               
               
                   
               
               
                 RISATWQFVLNNTVDGKLDELNWGSYNKVVNACLETGAYCMIDMHNFARYNGGIIGQGGVSDDIFVDLWVQIAKY 
               
               
                   
               
               
                 YEDNDKIIFGLMNEPHDLDIEIWAQTCQKVVTAIRKAGATSQMILLPGTNFASVETYVSTGSAEALGKITNPDGS 
               
               
                   
               
               
                 TDLLYFDVHKYLDINNSGSHAECTTDNVDAFNDFADWLRQNKRQAIISETGASMEPSCMTAFCAQNKAISENSDV 
               
               
                   
               
               
                 YIGFVGWGAGSFDTSYILTLTPLGKPGNYTDNKLMNECILDQFTLDEKYRPTPTSISTAAEETATATATSDGDAP 
               
               
                   
               
               
                 STTKPIFREETASPTPNAVTKPSPDTSDSSDDDKDSAASMSAQGLTGTVLFTVAALGYMLVAF 
               
               
                   
               
               
                 GLR1 
               
               
                 (SEQ ID NO: 13) 
                   
               
               
                 MVIRSLLLLLLAAIVPVFAESGIDAWLRYARLPSSATRGHLTSFPDRIVVLNASKNGPLASASSELHKGIKGILG 
                   
               
               
                   
               
               
                 LDLDVSSRGGKHCSTQKSIVISTLDTYQSACGKLSPKLNLKEDGYWLSTKGGSVQIIGQNERGALYGAFQYLSYL 
               
               
                   
               
               
                 GQGDFSGKAFASNPSAPVRWSNQWDNLNAATAAHGSIERGYGGPSIFFENGLIKEDLSRVPLYGRLLASVGLNGI 
               
               
                   
               
               
                 VINNVNADANLLNETNLQGLKRIADLFRPWGVNVGISLNFASPQVLGDLSTFDPLDDSVIKWWTDKTDRIYQLVP 
               
               
                   
               
               
                 DLAGYLVKANSEGQPGPLTYNRTLAEGANLFAKAVQPHGGIVVFRAFVYDQLNETDWKADRANAAVDFFKSLDGQ 
               
               
                   
               
               
                 FDDNVLVQIKYGPIDFQVREPASPLFANLPKTAVSIELEVTQEYLGQQSHLVYLPPLWQTVLGFDMRYNNRQSYV 
               
               
                   
               
               
                 RDIISGEVFGHKLGGYAGVINVGMDDTWLGSHLAMSNMFAYGRLAWNPRADSRDIVEEWTRLTFGLDRDVVSTIA 
               
               
                   
               
               
                 DMSLKSWPAYEGYSGNLGIQTLTDILYTHYGANPASQDNNGWGQWTRADSKTIGMDRTVSNGTGNAGQYPKEVAA 
               
               
                   
               
               
                 RFEHTQTTPDDLMLWFHHVPYTFRLHSGKSVIQHFYDAHYTGAATVQRFPAAWKSLKSKIDTERYNAVLYKLQYQ 
               
               
                   
               
               
                 TGHSLVWRDAITEFYRNLSSIPDQLNRVRNHPHRIEAEDMDLSGFTVVNVSPTECASKYKAIATNGTGTATTRLN 
               
               
                   
               
               
                 VPSGKYTVAVNYYDVINGTASYDVLLNGKSLGKWKGDSETHLGHDFSTFLDCHSAIRITFEGVRISRGDKLTIRG 
               
               
                   
               
               
                 TGNAQEQAAIDYVSILPQGVVD 
               
               
                   
               
               
                 MAN1 
               
               
                 (SEQ ID NO: 14) 
                   
               
               
                 MMMLSKSLLSAATAASALAAVLQPVPRASSFVTISGTQFNIDGKVGYFAGTNCYWCSFLTNHADVDSTFSHISSS 
                   
               
               
                   
               
               
                 GLKVVRVWGFNDVNTQPSPGQIWFQKLSATGSTINTGADGLQTLDYVVQSAEQHNLKLIIPFVNNWSDYGGINAY 
               
               
                   
               
               
                 VNAFGGNATTWYTNTAAQTQYRKYVQAVVSRYANSTAIFAWELGNEPRCNGCSTDVIVQWATSVSQYVKSLDSNH 
               
               
                   
               
               
                 LVTLGDEGLGLSTGDGAYPYTYGEGTDFAKNVQIKSLDFGTFHLYPDSWGTNYTWGNGWIQTHAAACLAAGKPCV 
               
               
                   
               
               
                 FEEYGAQQNPCTNEAPWQTTSLTTRGMGGDMFWQWGDTFANGAQSNSDPYTVWYNSSNWQCLVKNHVDAINGGTT 
               
               
                   
               
               
                 TPPPVSSTTTTSSRTSSTPPPPGGSCSPLYGQCGGSGYTGPTCCAQGTCIYSNYWYSQCLNT 
               
               
                   
               
               
                 PEC2 
               
               
                 (SEQ ID NO: 15) 
                   
               
               
                 MLKLSLFLGAVTASLCVQAHAVPPPTVTQAPKLEDRATTCTFSGSNGASSASKSQKSCATIVLSNVAVPSGVTLD 
                   
               
               
                   
               
               
                 LSDLNDGTTVIFEGTTTWGYKEWSGPLLQIEGNDITIQGASGAVLNPDGARWWDGQGGNGGKTKPKFFAAHDLTS 
               
               
                   
               
               
                 SSITNLYIKNTPVQAVSVNGVNGLTITGMTIDNSAGDSGGGHNTDGFDIGSSSNVVISGAKVYNQDDCVAVNSGT 
               
               
                   
               
               
                 NITFTGGLCSGGHGLSIGSVGGRDDNTVQTVTFSNSQVTKSANGIRIKATAGKTGTIKGVTYTGITLSSITGYGI 
               
               
                   
               
               
                 LIEQNYDGGDLHGSPTSGIPITNLVLQNISGSNGVVSSGNNIAIVCGSGACSNWTWSNVVVTGGKKYGSCQNVPS 
               
               
                   
               
               
                 PATC 
               
               
                   
               
               
                 XYN1 
               
               
                 (SEQ ID NO: 16) 
                   
               
               
                 MVAFSSLICALTSIASTLAMPTGLEPESSVNVTERGMYDFVLGAHNDHRRRASINYDQNYQTGGQVSYSPSNTGF 
                   
               
               
                   
               
               
                 SVNWNTQDDFVVGVGWTTGSSAPINFGGSFSVNSGTGLLSVYGWSTNPLVEYYIMEDNHNYPAQGTVKGTVTSDG 
               
               
                   
               
               
                 ATYTIWENTRVNEPSIQGTATFNQYISVRNSPRTSGTVTVQNHFNAWASLGLHLGQMNYQVVAVEGWGGSGSASQ 
               
               
                   
               
               
                 SVSN 
               
               
                   
               
               
                 BXL1 
               
               
                 (SEQ ID NO: 17) 
                   
               
               
                 MVNNAALLAALSALLPTALAQNNQTYANYSAQGQPDLYPETLATLTLSFPDCEHGPLKNNLVCDSSAGYVERAQA 
                   
               
               
                   
               
               
                 LISLFTLEELILNTQNSGPGVPRLGLPNYQVWNEALHGLDRANFATKGGQFEWATSFPMPILTTAALNRTLIHQI 
               
               
                   
               
               
                 ADIISTQARAFSNSGRYGLDVYAPNVNGFRSPLWGRGQETPGEDAFFLSSAYTYEYITGIQGGVDPEHLKVAATV 
               
               
                   
               
               
                 KHFAGYDLENWNNQSRLGFDAIITQQDLSEYYTPQFLAAARYAKSRSLMCAYNSVNGVPSCANSFFLQTLLRESW 
               
               
                   
               
               
                 GFPEWGYVSSDCDAVYNVFNPHDYASNQSSAAASSLRAGTDIDCGQTYPWHLNESFVAGEVSRGEIERSVTRLYA 
               
               
                   
               
               
                 NLVRLGYFDKKNQYRSLGWKDVVKTDAWNISYEAAVEGIVLLKNDGTLPLSKKVRSIALIGPWANATTQMQGNYY 
               
               
                   
               
               
                 GPAPYLISPLEAAKKAGYHVNFELGTEIAGNSTTGFAKAIAAAKKSDAIIYLGGIDNTIEQEGADRTDIAWPGNQ 
               
               
                   
               
               
                 LDLIKQLSEVGKPLVVLQMGGGQVDSSSLKSNKKVNSLVWGGYPGQSGGVALFDILSGKRAPAGRLVTTQYPAEY 
               
               
                   
               
               
                 VHQFPQNDMNLRPDGKSNPGQTYIWYTGKPVYEFGSGLFYTTFKETLASHPKSLKFNTSSILSAPHPGYTYSEQI 
               
               
                   
               
               
                 PVFTFEANIKNSGKTESPYTAMLFVRTSNAGPAPYPNKWLVGFDRLADIKPGHSSKLSIPIPVSALARVDSHGNR 
               
               
                   
               
               
                 IVYPGKYELALNTDESVKLEFELVGEEVTIENWPLEEQQIKDATPDA 
               
             
          
         
       
     
         [0078]    Secreted protein broths expressing ABF1, ABF2, ABF3, AGL1, AGL2, AGL3, AXE1, AXE3, EG6, EG8, GLR1, MAN1, PEC2, XYN1, XYN3, and BXL1 were tested in ternary mixes. 150 μl AFEX-pretreated corn stover (31.7% glucan, 19.1% xylan, 1.83% galactan, and 3.4% of arabinan, based on dry weight, made as either a 15.6 or 12% solids slurry in pH 5 50 mM sodium acetate buffer) was added to each well of a 96-well microtiter plate (all data points are based on triplicate wells). One experiment (shown in Table 9) employed dilute ammonia-pretreated corn cob at 13.84% solids as the substrate. To selected wells was added ACCELLERASE 1000™ (CEL) alone at 20 mg/G cellulose, ACCELLERASE 1000™ at 20 mg/G+5 mg/G MULTIFECT® Xylanase, or ACCELLERASE 1000™ at 20 mg/G+5 mg/G MULTIFECT® Xylanase+1 or 5 mg/G of individual hemicellulase broths all in 20 μl total enzyme volume. 
         [0079]    Enzyme doses were adjusted for total cellulose in either substrate slurry (15.6% or 12% solids). Plates were sealed and incubated with shaking at 50° C. for 72 hours. Reactions were then quenched with 100 μl 100 mM glycine, pH 10. This mix was filtered and diluted an additional 6× (20 μl+100 μl distilled H 2 O) and analyzed for sugar content on an HPLC-Aminex HPX-87P column on an Agilent Chem Station HPLC instrument. HPLC peak areas were converted to sugar concentrations based on a cellobiose standard curve for cellobiose and glucose or on a xylose standard curve for xylose. Percent conversion based on starting cellulose content was calculated to include H 2 O of hydrolysis for each of the three sugar polymers. Standard deviations of triplicates were also calculated. 
         [0080]    Table 2 and 3 provide the mean conversion (±standard deviation) of glucans and of xylans for each enzyme mixture as determined in two separate executions of the protocol. These separate runs were performed with the two different AFEX substrate slurries of 15.6% (Table 2) and 12% solids (Table 3) and thus include different total mgs of cellulose, though the dose as mg/G cellulose is the same. 
         [0000]    
       
         
               
               
               
             
               
               
               
               
             
           
               
                 TABLE 2 
               
               
                   
               
               
                   
                 % conversion 
                 % conversion 
               
               
                   
                 glucan 
                 xylan 
               
               
                 Enzyme 
                 (±SD) 
                 (±SD) 
               
               
                   
               
             
             
               
                 20 mg/G CEL 
                  56.31 (0.88) 
                  39.47 (0.66) 
               
               
                 25 mg/G CEL 
                  61.12 (0.99) 
                 41.82 (1.6) 
               
               
                 30 mg/G CEL 
                 66.48 (1.9) 
                  46.69 (0.98) 
               
             
          
           
               
                 20 mg/G CEL + 
                 — 
                 67.92 (1.1) 
                 61.02 (1.3) 
               
               
                 5 mg/G XYN2 
                 +5 mg/G ABF1 
                 68.84 (2.1) 
                  62.31 (0.67) 
               
               
                   
                 +5 mg/G ABF2 
                 74.84 (2.4) 
                 62.36 (1.2) 
               
               
                   
                 +5 mg/G ABF3 
                 72.96 (1.4) 
                 63.35 (3.7) 
               
               
                   
                 +5 mg/G AXE1 
                 71.93 (1.4) 
                  64.78 (0.83) 
               
               
                   
                 +5 mg/G BXL1 
                 78.45 (2.8) 
                 79.29 (4.9) 
               
               
                   
                 +5 mg/G EG6 
                 70.15 (2.1) 
                 58.82 (2.7) 
               
               
                   
                 +5 mg/G GLR1 
                 67.81 (1.8) 
                 65.70 (2.9) 
               
               
                   
                 +5 mg/G MAN1 
                  74.58 (0.80) 
                  66.84 (0.64) 
               
               
                   
                 +5 mg/G PEC2 
                 72.94 (4.3) 
                 61.99 (5.5) 
               
               
                   
                 +5 mg/G XYN1 
                 67.33 (1.1) 
                  62.22 (0.44) 
               
               
                   
                 +5 mg/G XYN3 
                  78.82 (0.64) 
                  73.63 (0.50) 
               
               
                   
                 +1 mg/G XYN3 + 
                 77.37 (2.6) 
                 74.44 (2.3) 
               
               
                   
                 1 mg/G BXL1 
               
               
                   
               
             
          
         
       
     
         [0000]    
       
         
               
               
               
             
               
               
               
               
             
           
               
                 TABLE 3 
               
               
                   
               
               
                   
                 % conversion 
                 % conversion 
               
               
                   
                 glucan 
                 xylan 
               
               
                 Enzyme 
                 (±SD) 
                 (±SD) 
               
               
                   
               
             
             
               
                 20 mg/G CEL 
                 55.08 (1.8) 
                 35.95 (0.94) 
               
               
                 30 mg/G CEL 
                  62.63 (0.96) 
                 40.99 (0.30) 
               
             
          
           
               
                 20 mg/G CEL + 
                 — 
                  63.96 (0.58) 
                 55.06 (2.0)  
               
               
                 5 mg/G XYN2 
                 +5 mg/G AGL1 
                 67.52 (1.7) 
                 56.00 (1.2)  
               
               
                   
                 +5 mg/G AGL2 
                 69.80 (2.7) 
                 55.02 (1.8)  
               
               
                   
                 +5 mg/G AGL3 
                  66.51 (0.12) 
                 55.93 (0.59) 
               
               
                   
                 +5 mg/G AXE3 
                 68.32 (1.4) 
                 55.89 (0.67) 
               
               
                   
                 +5 mg/G EG8 
                 70.68 (3.9) 
                 55.40 (2.7)  
               
               
                   
               
             
          
         
       
     
         [0081]    The addition of XYN2 was effective in increasing xylan conversion. Six enzyme mixtures with a third component (i.e., XYN3, AGL2, EG8, BXL1, ABF3, or PEC2) showed further advantages in terms of glucan and/or xylan conversion compared to cellulase with XYN2. A quaternary enzyme mix was run according to the procedure described above. Table 4 provides the mean conversion (±standard deviation) of glucans and xylans for each enzyme mixture. 
         [0000]    
       
         
               
               
               
             
               
               
               
               
             
           
               
                 TABLE 4 
               
               
                   
               
               
                   
                 % conversion 
                 % conversion 
               
               
                   
                 glucan 
                 xylan 
               
               
                 Enzyme 
                 (±SD) 
                 (±SD) 
               
               
                   
               
             
             
               
                 20 mg/G CEL 
                 55.43 (6.5) 
                 42.29 (2.3) 
               
               
                 20 mg/G CEL + 5 mg/G XYN2 
                  71.27 (0.67) 
                 63.96 (1.2) 
               
               
                 20 mg/G CEL + 5 mg/G XYN3 
                 85.07 (3.1) 
                 68.69 (2.6) 
               
               
                 20 mg/G CEL + 5 XYN2 + 
                 86.82 (1.2) 
                  80.68 (0.33) 
               
               
                 5 mg/G XYN3 
               
             
          
           
               
                 20 mg/G CEL + 
                 — 
                  76.57 (0.94) 
                  72.70 (0.64) 
               
               
                 5 mg/G XYN2 + 
                 +5 mg/G ABF3 
                  81.58 (0.76) 
                  75.89 (0.73) 
               
               
                 2.5 XYN3 
                 +5 mg/G AGL2 
                 78.66 (2.7) 
                 72.49 (2.3) 
               
               
                   
                 +5 mg/G BXL1 
                 72.80 (6.7) 
                 78.60 (2.1) 
               
               
                   
                 +5 mg/G EG8 
                 74.72 (6.0) 
                 73.29 (2.8) 
               
               
                   
                 +5 mg/G PEC2 
                 78.18 (2.4) 
                 73.90 (2.9) 
               
               
                   
               
             
          
         
       
     
         [0082]    In another experiment, ACCELLERASE 1000™ was mixed with purified XYN2 and/or XYN3 and assayed (Table 5). The combination of XYN2 and XYN3 produced more efficient glucan and xylan conversion. 
         [0000]    
       
         
               
               
               
             
               
               
               
               
             
               
               
               
             
           
               
                 TABLE 5 
               
               
                   
               
               
                   
                 % conversion 
                 % conversion 
               
               
                   
                 glucan 
                 xylan 
               
               
                 Enzyme 
                 (±SD) 
                 (±SD) 
               
               
                   
               
             
             
               
                   
               
             
          
           
               
                 10 mg/G CEL 
                 — 
                 43.97 (1.4) 
                 28.41 (1.0) 
               
               
                   
                 +10 mg/G XYN2 
                 59.22 (4.3) 
                 56.83 (5.7) 
               
               
                   
                 +10 mg/G XYN3 
                 51.44 (8.6) 
                 43.53 (1.6) 
               
               
                 20 mg/G CEL 
                 — 
                 60.29 (1.7) 
                  40.02 (0.33) 
               
               
                   
                 +5 mg/G XYN2 + 
                  73.73 (0.79) 
                 61.81 (1.2) 
               
               
                   
                 5 mg/G XYN3 
               
               
                   
                 +10 mg/G XYN2 + 
                 74.71 (1.6) 
                 65.20 (1.4) 
               
               
                   
                 10 mg/G XYN3 
               
             
          
           
               
                 30 mg/G CEL 
                  67.05 (0.74) 
                  43.74 (0.14) 
               
               
                   
               
             
          
         
       
     
         [0083]    In a further example, XYN4, XYN5, FAE1 and a new lot of ABF3 with ˜50% protein of interest (compared to previous lot at &lt;10%) were tested as above in mixtures containing 20 mg/G ACCELLERASE 1000™+5 mg/G MULTIFECT® Xylanase XYN2. The results are shown in Table 6. The addition of XYN4, XYN5, or FAE1 was effective in increasing the conversion of glucan and xylan. 
         [0000]    
       
         
               
               
               
             
               
               
               
               
             
           
               
                 TABLE 6 
               
               
                   
               
               
                   
                 % conversion 
                 % conversion 
               
               
                   
                 glucan 
                 xylan 
               
               
                 Enzyme 
                 (±SD) 
                 (±SD) 
               
               
                   
               
             
             
               
                 20 mg/G CEL 
                 57.52 (1.08) 
                 38.37 (0.38) 
               
               
                 30 mg/G CEL 
                 66.21 (1.37) 
                 44.15 (0.70) 
               
             
          
           
               
                 20 mg/G CEL + 
                 — 
                 68.44 (0.23) 
                 60.46 (0.48) 
               
               
                 5 mg/G XYN2 
                 +5 mg/G ABF3 
                 66.22 (5.99) 
                 67.46 (3.97) 
               
               
                   
                 +5 mg/G XYN4 
                 72.17 (0.66) 
                 63.47 (0.44) 
               
               
                   
                 +5 mg/G XYN5 
                 71.91 (3.74) 
                 62.73 (3.37) 
               
               
                   
                 +5 mg/G FAE1 
                 70.98 (1.47) 
                 67.02 (1.59) 
               
               
                   
               
             
          
         
       
     
         [0084]    In another experiment, ACCELLERASE 1000™ was mixed with purified Bxl1 and XYN2 and/or XYN3 and assayed as above. The results are shown in Table 7. Several enzyme combinations were effective in increasing the conversion of glucan and/or xylan. 
         [0000]    
       
         
               
               
               
             
           
               
                 TABLE 7 
               
               
                   
               
               
                   
                 % conversion 
                 % conversion 
               
               
                   
                 glucan 
                 xylan 
               
               
                 Enzyme 
                 (±SD) 
                 (±SD) 
               
               
                   
               
             
             
               
                 35 mg/G CEL 
                 67.95 (0.67) 
                 40.36 (0.36) 
               
               
                 30 mg/G CEL 
                 66.51 (1.99) 
                 38.63 (0.56) 
               
               
                 20 mg/G CEL 
                 58.03 (3.19) 
                 32.28 (1.41) 
               
               
                 10 mg/g CEL 
                 45.01 (0.59) 
                 23.85 (0.42) 
               
               
                 10 mg/g CEL + 10 mg/G BXL1 
                 46.89 (4.16) 
                 48.85 (2.94) 
               
               
                 20 CEL + 5 XYN2 + 5 BXL1 
                 69.45 (4.88) 
                 60.15 (1.17) 
               
               
                 20 CEL + 5 XYN3 + 5 BXL1 
                 65.17 (8.37) 
                 65.36 (1.14) 
               
               
                 20 CEL + 5 XYN2 + 5 XYN3 + 
                 75.13 (1.20) 
                 66.97 (1.07) 
               
               
                 5 BXL1 
               
               
                   
               
             
          
         
       
     
         [0085]    In another example, ABF1, ABF2 and ABF3 (ABF3 sample lot with &lt;10% protein of interest), singly, in binary and ternary combinations were added to a background of 20 mg/G ACCELLERASE 1000™+5 mg/G purified XYN3+5 mg/G purified BXL1. The results are shown in Table 8. Several enzyme combinations were effective in increasing the conversion of glucan and/or xylan. 
         [0000]    
       
         
               
               
               
             
               
               
               
               
             
           
               
                 TABLE 8 
               
               
                   
               
               
                   
                 % conversion 
                 % conversion 
               
               
                   
                 glucan 
                 xylan 
               
               
                 Enzyme 
                 (±SD) 
                 (±SD) 
               
               
                   
               
             
             
               
                 30 mg/G CEL 
                 67.55 (0.18) 
                 45.05 (6.67) 
               
               
                 45 mg/G CEL 
                 79.39 (4.66) 
                 56.05 (2.31) 
               
             
          
           
               
                 20 mg/G CEL + 
                 — 
                 73.24 (4.39) 
                 79.88 (4.72) 
               
               
                 5 mg/GXYN3 + 
                 +5 mg/G ABF1 
                 58.21 (0.55) 
                 86.84 (0.47) 
               
               
                 5 mg/G BXL1 
                 +5 mg/G ABF2 
                 84.39 (1.01) 
                 87.15 (1.32) 
               
               
                   
                 +5 mg/G ABF3 
                 65.07 (3.68) 
                 73.46 (4.13) 
               
               
                   
                 +5 mg/GABF1 + 
                 87.65 (3.11) 
                 87.08 (2.31) 
               
               
                   
                 5 mg/G ABF2 
               
               
                   
                 +5 mg/GABF1 + 
                 67.62 (5.01) 
                 87.77 (2.91) 
               
               
                   
                 5 mg/G ABF3 
               
               
                   
                 +5 mg/GABF2 + 
                 91.21 (1.82) 
                 89.98 (1.08) 
               
               
                   
                 5 mg/G ABF3 
               
               
                   
                 +5 mg/GABF1 + 
                 99.67 (3.45) 
                 96.73 (4.74) 
               
               
                   
                 5 mg/G ABF2 + 
               
               
                   
                 5 mg/G ABF3 
               
               
                   
               
             
          
         
       
     
         [0086]    In another example 3.4 mg/G xylan of purified ABF1, ABF2 and/or ABF3 were added to a 20.7 mg/G glucan of ACCELLERASE 1000™+5.1 mg/G xylan each of purified XYN3 and BXL1. The results are shown in Table 9. Several enzyme combinations were effective in increasing the conversion of glucan and/or xylan. 
         [0000]    
       
         
               
               
               
             
               
               
               
               
             
           
               
                 TABLE 9 
               
               
                   
               
               
                   
                 % conversion 
                 % conversion 
               
               
                   
                 glucan 
                 xylan 
               
               
                 Enzyme 
                 (±SD) 
                 (±SD) 
               
               
                   
               
             
             
               
                 30.9 mg/G CEL 
                 66.45 (1.64) 
                 33.84 (0.83) 
               
               
                 41.3 mg/G CEL 
                 67.99 (0.57) 
                 35.95 (0.11) 
               
             
          
           
               
                 20.7 mg/G CEL + 
                 — 
                 76.67 (0.30) 
                 63.86 (0.08) 
               
               
                 5.1 mg/GXYN3 + 
                 +3.4 mg/G ABF1 
                 76.37 (1.32) 
                 64.18 (1.77) 
               
               
                 5.1 mg/G BXL1 
                 +3.4 mg/G ABF2 
                 77.84 (1.48) 
                 66.59 (2.07) 
               
               
                   
                 +3.4 mg/G ABF3 
                 77.53 (1.94) 
                 66.86 (1.84) 
               
               
                   
                 +3.4 mg/G ABF1 + 
                 78.32 (1.56) 
                 67.65 (2.31) 
               
               
                   
                 3.4 mg/GABF2 
               
               
                   
                 +3.4 mg/G ABF1 + 
                 77.53 (1.04) 
                 66.89 (0.51) 
               
               
                   
                 3.4 mg/G ABF3 
               
               
                   
                 +3.4 mg/G ABF2 + 
                 79.92 (0.27) 
                 68.96 (0.03) 
               
               
                   
                 3.4 mg/G ABF3 
               
               
                   
                 +3.4 mg/G ABF1 + 
                 80.22 (1.98) 
                 68.76 (2.22) 
               
               
                   
                 3.4 mg/G ABF2 + 
               
               
                   
                 3.4 mg/G ABF3